The hypoxic tumour microenvironment

V Petrova, M Annicchiarico-Petruzzelli, G Melino… - Oncogenesis, 2018 - nature.com
Cancer progression often benefits from the selective conditions present in the tumour
microenvironment, such as the presence of cancer-associated fibroblasts (CAFs) …

Senescence and aging: the critical roles of p53

A Rufini, P Tucci, I Celardo, G Melino - Oncogene, 2013 - nature.com
Abstract p53 functions as a transcription factor involved in cell-cycle control, DNA repair,
apoptosis and cellular stress responses. However, besides inducing cell growth arrest and …

A designed inhibitor of p53 aggregation rescues p53 tumor suppression in ovarian carcinomas

A Soragni, DM Janzen, LM Johnson, AG Lindgren… - Cancer cell, 2016 - cell.com
Half of all human cancers lose p53 function by missense mutations, with an unknown
fraction of these containing p53 in a self-aggregated amyloid-like state. Here we show that a …

p53 family and cellular stress responses in cancer

J Pflaum, S Schlosser, M Müller - Frontiers in oncology, 2014 - frontiersin.org
p53 is an important tumor suppressor gene, which is stimulated by cellular stress like
ionizing radiation, hypoxia, carcinogens, and oxidative stress. Upon activation, p53 leads to …

DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors

T Mazor, A Pankov, BE Johnson, C Hong, EG Hamilton… - Cancer cell, 2015 - cell.com
The evolutionary history of tumor cell populations can be reconstructed from patterns of
genetic alterations. In contrast to stable genetic events, epigenetic states are reversible and …

The Janus-like role of proline metabolism in cancer

L Burke, I Guterman, R Palacios Gallego… - Cell death …, 2020 - nature.com
The metabolism of the non-essential amino acid L-proline is emerging as a key pathway in
the metabolic rewiring that sustains cancer cells proliferation, survival and metastatic …

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope

A Zafar, W Wang, G Liu, W Xian, F McKeon, J Zhou… - Cancer letters, 2021 - Elsevier
Despite being the subject of extensive research and clinical trials, neuroblastoma remains a
major therapeutic challenge in pediatric oncology. The p53 protein is a central safeguard …

Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy

M Prokocimer, A Molchadsky… - Blood, The Journal of the …, 2017 - ashpublications.org
The heterogeneous nature of acute myeloid leukemia (AML) and its poor prognosis
necessitate therapeutic improvement. Current advances in AML research yield important …

Links between mutant p53 and genomic instability

W Hanel, UM Moll - Journal of cellular biochemistry, 2012 - Wiley Online Library
The tumor suppressor p53 has long been known to play a central role in maintaining a
stable genome in the face of toxic insults through its role in promoting cell‐cycle …

[HTML][HTML] Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds

ARMR Amin, PA Karpowicz, TE Carey, J Arbiser… - Seminars in cancer …, 2015 - Elsevier
The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to
continue to proliferate, cancer cells must somehow uncouple themselves from the many …